Open original FDA record ↗Recall record
- FDA identifier
- Z-1901-2011
- Company in FDA record
- Gambro Renal Products, Incorporated
- FDA classification date
- Apr 6, 2011
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 17, 2026
- Recall classification
- Unknown — no matched enforcement classification
Reason stated in the source
Prismaflex touch screen may become unresponsive during Continuous Renal Replacement Therapy procedure.
Source facts
- Action
- The firm, GAMBRO Renal Products, sent an "URGENT - MEDICAL DEVICE RECALL" letter dated March 14, 2011 to all customers. The letter described the product, problem and actions to be taken. The customers were provided with response procedures to use if the frozen screen problem occurs while using the product. The customers were instructed to closely monitor the return line for potential air and/or clots in the circuit; review the instructions provided in the attached copy of Chapter 5: Troubleshooting, "Softkeys won't work." of the Prismaflex Operators Manual in conjunction with the attached Troubleshooting Checklist; be aware if performing Manual Termination with Blood Return, air detection is not provided, and complete and return the Customer Reply Form via fax to: Regulatory Affairs at 1-866-447-4471 or 303-222-6916, or by email to: GRPRegulatory.Affairs@us.gambro.com. If you have any questions or concerns, please contact for Clinical questions: ICON 800-554-1312 (available 24/7) or your local Gambro Representative; for Technical questions: Gambro Customer Support 800-525-2623, option 2 (Available 6:00am to 5:30pm MT, Monday thru Friday).
- Initiated
- 2011-03-14
- Root cause
- Software change control
- Terminated
- 2011-09-01
- Distribution
- Nationwide distribution.
- Recall number
- Z-1901-2011
- Recall status
- Terminated
- CDRH record ID
- 98675
- FDA classified
- 2011-04-06
- Recall event number
- 58208